Fecal microbiota transplantation in treating Clostridium difficile infection

Area of Science:

• Gastroenterology
• Infectious Diseases
• Microbiology

Background:

• Clostridium difficile infection (CDI) presents a significant global health challenge.
• Conventional antibiotic treatments for CDI often lack efficacy and lead to frequent recurrence.
• Intestinal dysbiosis is a key characteristic of recurrent or refractory CDI.

Purpose of the Study:

• To review the current evidence and experiences with fecal microbiota transplantation (FMT) for treating CDI.
• To highlight FMT as a promising alternative for recurrent or refractory CDI cases.
• To discuss the potential mechanisms behind FMT's effectiveness in CDI.

Main Methods:

• Review of existing literature and reported clinical experiences with FMT in CDI patients.
• Summary of practical administration methods for fecal microbiota transplantation.
• Analysis of the effectiveness and safety of FMT based on current data.

Main Results:

• Fecal microbiota transplantation (FMT) has emerged as an effective and generally safe treatment option for recurrent or refractory CDI.
• FMT likely functions by correcting the intestinal dysbiosis associated with CDI.
• Various practical methods for FMT administration have been documented.

Conclusions:

• Fecal microbiota transplantation (FMT) represents a significant advancement in managing challenging Clostridium difficile infections.
• The restoration of a healthy gut microbiome through FMT is crucial for successful CDI treatment.
• Further research into FMT mechanisms and standardization is warranted.